EUVIMEDEUVIMED entdecken
Fall-Kontroll-StudieOpen Access · CC BY-NC 4.0

Clinical and Para-clinical Findings of COVID19 in Hemodialysis Patients Compared to Control Group: A Case-Control Study

Elham Shahreki, AliReza Ansari-Moghaddam, Roya Alavi Naini, Maryam Keikha, Ramin Bazi, Ahmad Reza Shahraki

Nephro-Urology Monthly · 2022

DOI: 10.5812/numonthly-122095 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift Nephro-Urology Monthly, 2022. Verfasst von Elham Shahreki und 5 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Following the global outbreak of severe acute respiratory syndrome coronavirus 2 in different communities, hemodialysis patients have not been spared by this viral infection.

Objectives

This study evaluated the clinical symptoms laboratory and imaging findings in patients undergoing hemodialysis and compared these characteristics with the control group.

Methods

The study was performed on 72 patients with positive COVID-19 polymerase chain reaction test, of whom 36 cases had end-stage renal disease undergoing hemodialysis and the remaining had no history of kidney diseases. After matching the two groups in terms of age, sex, and other underlying diseases, the clinical, laboratory, and chest computed tomography (CT) scan findings were compared between the case and control groups.

Results

The mean age of dialysis patients was 42.52 ± 12.10 years and 48.58 ± 17.35 years in the control group. The study results revealed that hemodialysis patients had less fever, cough, and shortness of breath than the control group (P-value < 0.05). Hemoglobin, lymphocyte, and platelet counts were significantly lower in hemodialysis patients in comparison to the control group (P-value < 0.05). C-reactive protein was significantly higher in patients undergoing hemodialysis (P-value < 0.05), and ground-glass opacification was observed more in patients undergoing hemodialysis compared to controls, but this difference was not statically significant (P > 0.05).

Conclusions

Hemodialysis patients had fewer initial clinical symptoms but more abnormalities in laboratory findings and ground-glass opacities on chest CT scans and a higher mortality rate.

Zitieren

APA

Shahreki, E., Ansari-Moghaddam, A., Naini, R. A., Keikha, M., Bazi, R., & Shahraki, A. R. (2022). Clinical and Para-clinical Findings of COVID19 in Hemodialysis Patients Compared to Control Group: A Case-Control Study. Nephro-Urology Monthly. https://doi.org/10.5812/numonthly-122095

Vancouver

Shahreki E, Ansari-Moghaddam A, Naini RA, Keikha M, Bazi R, Shahraki AR. Clinical and Para-clinical Findings of COVID19 in Hemodialysis Patients Compared to Control Group: A Case-Control Study. Nephro-Urology Monthly. 2022. doi:10.5812/numonthly-122095

BibTeX
@article{Shahreki2022,
  author = {Shahreki, Elham and Ansari-Moghaddam, AliReza and Naini, Roya Alavi and Keikha, Maryam and Bazi, Ramin and Shahraki, Ahmad Reza},
  title = {Clinical and Para-clinical Findings of COVID19 in Hemodialysis Patients Compared to Control Group: A Case-Control Study},
  journal = {Nephro-Urology Monthly},
  year = {2022},
  doi = {10.5812/numonthly-122095}
}
Kostenlos starten →